How should cortisol be evaluated in a patient suspected of Addison disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Check Cortisol in Addison Disease

The diagnosis of Addison disease (primary adrenal insufficiency) requires paired measurement of morning (8 AM) serum cortisol and plasma ACTH, with a high-dose cosyntropin stimulation test (250 mcg) performed when baseline values are equivocal. 1, 2

Diagnostic Algorithm

Step 1: Initial Screening - Morning Cortisol and ACTH

  • Draw blood at 8 AM for simultaneous measurement of:
    • Serum cortisol
    • Plasma ACTH

Interpretation of baseline values:

  • Cortisol <140 nmol/L (5 μg/dL) + ACTH >2× upper limit of normal → Confirms primary adrenal insufficiency 1
  • Cortisol <250 nmol/L + elevated ACTH in acute illness → Diagnostic of primary AI 2
  • Cortisol 250-400 nmol/L + elevated ACTH in acute illness → Strong suspicion, proceed to stimulation test 2
  • Cortisol >332 nmol/L (12 μg/dL) → Rules out adrenal insufficiency, no further testing needed 3
  • Cortisol <96 nmol/L → Highly predictive of inadequate adrenal reserve 3

Step 2: Cosyntropin Stimulation Test (When Baseline is Equivocal)

Perform high-dose (250 mcg) cosyntropin test:

  • Administer 250 mcg cosyntropin (tetracosactide) IV or IM
  • Measure cortisol at baseline and 30 minutes post-injection 1
  • The 30-minute time point is validated and preferred over 60 minutes 1

Diagnostic cutoffs:

  • Peak cortisol <500 nmol/L (18 μg/dL) → Confirms primary adrenal insufficiency 2
  • With newer immunoassays, a cutoff of ≥14.6 μg/dL may be more appropriate 4

Step 3: Confirm Mineralocorticoid Deficiency

Simultaneously measure plasma renin and aldosterone to assess for mineralocorticoid deficiency, which may be the earliest or only manifestation in evolving Addison disease 1

  • Elevated renin + low/normal aldosterone → Suggests primary AI 1, 5
  • This is particularly important as mineralocorticoid deficiency may predominate early in disease 1

Critical Pitfalls to Avoid

  1. Never delay treatment for diagnostic testing in suspected acute adrenal crisis 2. Draw baseline cortisol and ACTH, then immediately start hydrocortisone.

  2. ACTH assay variability: Different assays have significant analytical bias 1. The guideline recommends ACTH >2× upper limit of normal, though some patients may have values only slightly above the reference range 1.

  3. Low-dose (1 mcg) cosyntropin test: While potentially more sensitive for secondary AI, it adds no additional sensitivity or specificity for primary AI compared to the high-dose test 1. Use the standard 250 mcg dose for practical reasons.

  4. Timing matters: The 30-minute cortisol measurement is validated and preferred over the traditional 60-minute timepoint 1.

  5. Confounding factors: Exogenous steroids (oral prednisolone, dexamethasone, inhaled fluticasone) can confound interpretation of low cortisol levels 2.

Additional Diagnostic Considerations

Plasma ACTH concentration >300 ng/L (66 pmol/L) provides maximal adrenal stimulation, so a low cortisol with this ACTH level is highly predictive of primary AI 1. An elevated ACTH with normal-range cortisol can indicate early-stage disease 1.

In children under 2 years, the circadian cortisol rhythm is not established until after 4 months of age, making the Synacthen test the only feasible diagnostic test 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.